3613.HKEarnings Release财报快讯Media source媒体来源Source link原始来源August 28, 20262026/8/28by InvestLog AIInvestLog AI 整理

Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) 2026 H1 financial resultsBeijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) 2026 H1 财报发布

Key Results

Beijing Tong Ren Tang Chinese Medicine Company Limited reported revenue HK$602M, operating profit HK$216M, net income HK$201M, operating margin 35.8%.

Profitability and Cash Flow

Period: 2026 H1

Revenue: HK$602M; YoY: -21.0%

Gross profit: HK$385M; Gross margin: 63.9%; YoY: -16.9%

Operating profit: HK$216M; Operating margin: 35.8%; YoY: -18.8%

Net income: HK$201M; Earnings per share: HK$0.24; Net margin: 33.4%; YoY: -18.2%

Official release: 2026 Interim Results Announcement

核心结果

Beijing Tong Ren Tang Chinese Medicine Company Limited 公布2026 H1财报：营收 HK$602M，营业利润 HK$216M，净利润 HK$201M，营业利润率 35.8%。

财务指标

期间：2026 H1

营收：HK$602M；同比 -21.0%

毛利润：HK$385M；毛利率：63.9%；同比 -16.9%

营业利润：HK$216M；营业利润率：35.8%；同比 -18.8%

净利润：HK$201M；每股收益：HK$0.24；净利率：33.4%；同比 -18.2%

View 3613.HK stock details ->查看 3613.HK 个股详情 ->

For information only. Not investment advice.内容仅供参考，不构成投资建议。